Last Updated: May 10, 2026

Patent: 10,653,835

✉ Email this page to a colleague

Summary for Patent: 10,653,835

Title:	Integrated insulin delivery system with continuous glucose sensor
Abstract:	Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
Inventor(s):	John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
Assignee:	Dexcom Inc
Application Number:	US15/792,038
Patent Claims:	see list of patent claims

Details for Patent 10,653,835

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	SUSVIMO	ranibizumab	Injection	761197	October 22, 2021	10,653,835	2037-10-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,653,835

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	2019021596	⤷ Start Trial
United States of America	2019015020	⤷ Start Trial
United States of America	2018325437	⤷ Start Trial
United States of America	2018317824	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.